Skip links and keyboard navigation

Lost or stolen scheduled medicines

Licensees (manufacturers or wholesalers), clinicians and approval holders who are responsible for the manufacture, sale or distribution of scheduled medicines, are required to report discrepancies, losses or theft of these medicines to the Chief Executive, Department of Health.

Reporting obligations

The following tables show who has to report discrepancies losses or theft, and they outline the relevant details and reporting requirements (as outlined in the Regulation) for:

For more information read the Health (Drugs and Poisons) Regulation 1996.

Schedule 8 (controlled drugs)

WhoSchedule 8 (controlled drugs)—what the regulation states
Licensee (manufacturer or wholesaler)

The licensee must immediately give the chief executive written notice about the discrepancy, loss, misappropriation or theft (S50A).

Institutions (hospitals, nursing homes, detention centre, prison)

If the checker knows, or reasonably suspects, a controlled drug has been lost, misappropriated or stolen, immediately give the chief executive written notice about the loss, misappropriation or theft (S110).

Certain nursing practices and Queensland Ambulance Service stations

The person must immediately report to the chief executive—

(a) a contravention of this regulation; or
(b) an apparently excessive use of a controlled drug; or
(c) any inconsistency between the controlled drugs in stock and the controlled drugs that the records indicate should be in stock; or
(d) if the person knows, or reasonably suspects, a controlled drug has been lost, misappropriated or stolen, the person’s knowledge, or reasonable suspicion, of the
loss, misappropriation or theft (S113).

Places other than an institution (dentists, doctors, nurse practitioners, veterinary surgeons, community pharmacist)

The person must immediately give the chief executive a written notice about the discrepancy, loss, misappropriation or theft (S116A).
Approval holders

As per the condition of your approval for

  • Mine sites
  • Island resorts
  • University
  • Commercial paramedic service
  • Other approvals under section 18 of the regulation.

Schedule 4 (restricted drug)

WhoSchedule 4 (restricted drugs)—what the regulation states

Licensee (manufacturer or wholesaler)

If a licensee knows, or reasonably suspects that any of the following has been lost, misappropriated or stolen, the licensee must immediately give the chief executive a written notice about the loss, misappropriation or theft—

(a) a restricted drug that is an anabolic steroidal agent;

(b) a regulated restricted drug;

  • acitretin
  • etretinate
  • isotretinoin
  • thalidomide
  • dinoprost
  • dinoprostone
  • urofollitrophin (human follicle stimulating hormone)
  • luteinising hormone
  • clomiphene, cyclofenil or another substance specifically prepared to stimulate ovulation
  • clozapine
  • tretinoin
  • bosentan
  • bexarotene
  • teriparatide

(c) S4 pseudoephedrine (S144A).

Wholesale representative

A wholesale representative must immediately report the loss or theft of a restricted drug to the representative’s employer and the nearest police establishment (S151).

Approval holders

As per the condition of your approval for

  • Mine sites
  • Island resorts
  • University
  • Commercial paramedic service
  • Animal management and/or welfare
  • Other approvals under section 18 of the regulation

Schedule 3 (pseudoephedrine)

WhoSchedule 3 (pseudoephedrine)—what the regulation states

A person who sells S3 pseudoephedrine (e.g. pharmacist or licensees)

If a person who sells a poison that is S3 pseudoephedrine knows, or reasonably suspects, that any of the poison that is S3 pseudoephedrine has been lost, misappropriated or stolen, the person must immediately give the chief executive a written notice about the loss, misappropriation or theft (285B).

Last updated: 31 May 2017